Stock Code: 000028/200028 Notice No.: 2021 -37
Short Form of the Stock: SinopharmAccord /Accord B
China National Accord Medicines Corporation Ltd.
The Third Quarterly Report for 2021
The Company and whole members of the BOD guarantee that the information disclosed is true,
accurate and complete, and there are no any fictitious records, misleading statements or
important omissions.
Important content reminder:
1. Board of Directors, Supervisory Committee, all directors, supervisors and senior executives of China National
Accord Medicines Corporation Ltd. (hereinafter referred to as the Company) hereby confirm that there are no any
fictitious statements, misleading statements, or important omissions carried in this report, and shall take all
responsibilities, individual and/or joint, for the reality, accuracy and completion of the whole contents.
2. Principal of the Company, Person in Charge of Accounting Works and Person in Charge of Accounting Organ
(Accounting Officer) hereby confirm that the Financial Report of the Third Quarterly Report is authentic, accurate
and complete.
3. Whether theThird Quarterly Report has been audited or not
□Yes √No
I. Mainfinancial data
(i) Main accounting data and financial indexes
Whether it has retroactive adjustment or re-statement on previous accounting data or not
□Yes √No
Increase/decrease in Increase/decrease from
the period compared Year-begin to year-begin to
Current period with the same period period-end period-end compared
of the previous year with the same period
of the previous year
Operating income
(RMB) 17,046,925,131.18 8.51% 50,210,017,018.57 17.09%
Net profit attributable
to shareholders of the 332,710,261.54 -6.05% 1,074,155,274.79 7.68%
listed company (RMB)
Net profit attributable
to shareholders of the 323,929,049.31 -8.58% 1,044,883,457.53 6.48%
listed company after
deducting
non-recurring gains
and losses (RMB)
Net cash flow from
operating activities —— —— 1,420,066,537.79 -28.40%
(RMB)
Basic earnings per
share (RMB/Share) 0.78 -6.02% 2.51 7.73%
Diluted earnings per
share (RMB/Share) 0.78 -6.02% 2.51 7.73%
Weighted average ROE 2.29% 0.36 percentage point 7.51% 0.05 percentage point
down down
At the end of the Increase/decrease at the period-end compared
At the end of last year
reporting period with the end of the previous year
Totalassets (RMB) 44,855,599,672.17 39,594,533,471.65 13.29%
Net assets attributable
to shareholder of listed 14,679,445,950.04 13,948,322,652.33 5.24%
company (RMB)
(ii) Items and amountsof non-recurring profit (gains)/losses
√Applicable □ Not applicable
In RMB
Amount from
Item Amount for the year-begin to Note
period
period-end
Gains/losses from the dis posal of non-current asset
(including the write-off that accrued for Mainly the gains of disposalof the
1,412,736.93 610,707.82 right- of-use assets from store lease
impairment of assets) surrender.
Governmental subs idy reckoned into current
gains/losses (not including the subsidy enjoyed in Mainly the various specialsubsidies
quota or ration according to nat iona l standards, 14,898,997. 98 50,262,339.66 and tax rebates received in the
Period.
which are closely rele vant to enterprise’s bus iness)
When an enterprise acquires a subs idiary,
associated enterprise and joint venture
查看PDF原文
